Global Nuclear Imaging Devices Market 2019 Size Estimation, Share, Business Growth, Competitive Landscape to reach USD 2490 million till 2024

-

A new report on the Nuclear Imaging Devices Market, published by Market Research Future (MRFR), with Major Drivers, Mega Trends, Regional Overview during the forecast period (2018-2024). Considering the phenomenal growth, the market is witnessing currently; Market Research Future (MRFR) in its recently published study report asserts that Global Nuclear Imaging Devices Market will aggrandize exponentially by 2024 registering a massive CAGR of 5.2%

Market Leading Players
Some of the key players in the global nuclear imaging devices market are Philips Healthcare, Digirad Corporation, Neusoft Medical Systems Co., Ltd., Progenics Pharmaceuticals Inc., Cannon Inc., Surgiceye GmbH, CMR Naviscan, Mediso Medical Imaging Systems Ltd., Agfa-Gevaert Group, General Electric Company, DDD-Diagnostic A/S, Spectrum Dynamics Medical, FMI Medical Systems, Inc., Segamicorp, and others.
Nuclear Imaging Devices Market Outlook 2019 to 2024 is latest research Report published by “Market Research Future”. According to MRFR Global Nuclear Medicine Devices Market is projected to register a CAGR of 5.2% By 2023.Nuclear Imaging Devices Industry Analysis by Technology (PET, SPECT (Hybrid SPECT Systems and Standalone SPECT Systems) and Planar Scintigraphy)), Application (Oncology, Cardiology, Neurology and others), End User (Hospitals, Diagnostic Imaging Centers and others) and Region – Global Forecast till 2024

Nuclear Imaging Devices Market Highlights

The global nuclear imaging devices market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2490 million in 2018 and is projected to register a CAGR of 5.2% over the forecast period.

Key Questions Answered in This Report:

·         What will the market size and what will the growth rate be?
·         What are the key market trends?
·         What is driving this market?
·         What are the challenges to market growth?
·         Who are the key vendors in this market space?
·         What are the market opportunities and threats faced by the key vendors?

Nuclear Imaging Devices Market Segmentation

The global market for nuclear imaging devices, by technology, is segmented into positron emission tomography (PET), single photon emission computed tomography (SPECT), and planar scintigraphy. The single-photon-emission computed tomography (SPECT) are further classified as hybrid SPECT systems and standalone SPECT systems.

Based on application, the market is segmented into oncology, cardiology, neurology, and others.
Based on end user, the market is segmented into hospitals, diagnostic imaging centers, and others.
The diagnostic imaging centers segment is expected to witness the fastest growth over the forecast period due to rising adoption of nuclear imaging in diagnostic centers.

Table Of Content

1.            REPORT PROLOGUE
2.            MARKET INTRODUCTION
2.1.         Definition
2.2.         Scope of the Study
2.2.1.     Research Objective
2.2.2.     Assumptions
2.2.3.     Limitations         
3.            RESEARCH METHODOLOGY
3.1.         Overview
3.2.         Primary Research
3.3.         Secondary Research
3.4.         Market Size Estimation
4.            MARKET DYNAMICS
4.1.         Overview
4.2.         Drivers
4.3.         Restraints
4.4.         Opportunities

Continued….

ACCESS THE COMPLETE REPORT @ https://www.marketresearchfuture.com/reports/nuclear-imaging-devices-market-8014

Comments

Post a Comment

Popular posts from this blog

Insulin Delivery Devices Market Analysis Outlook 2025 By Top Manufactures Size, Trends, Demand and Growth Prospects 2020

-
  Insulin Delivery Devices Market Size, Application and Trends Analysis By Type (Insulin Syringes, Pen, Insulin Pumps, Insulin Jet Injectors, Pen Needles), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Sales And Diabetes Clinics/ Centers), End User and Region, Forecast Till 2025 The Global  Insulin Delivery Devices Market  size is estimated to grow at a  CAGR of 7.85%  and expected to reach  USD 21,804  Million by 2025, says Market Research Future (MRFR). Insulin, a glucose directing hormone, assumes a fundamental job in the whole treatment of diabetes. Insulin delivery frameworks help in infusing insulin into the greasy tissue under the skin. Factors, such as developing diabetic populace, innovative headways in insulin delivery systems, and favoring repayment arrangements, expanding mindfulness among shoppers on the accessibility of a few delivery devices and advancement of human insulin devices are relied upon to positively a...
Read more

Alpha-1 Antitrypsin Deficiency Treatment Market Overview by revenue and forecast to 2025

-
As of July 2019, 3.4 million people are affected by alpha-1 antitrypsin deficiency worldwide. The disorder is found to affect populations in all the regions of the world. The market is dominated by numerous established players. The key players are involved in product launches, strategic collaborations, and awareness programs to strengthen their market positions. For instance, in November 2018, Grifols S. A. launched the AlfaCare therapy program for training and counseling of patients diagnosed with alpha-1 antitrypsin deficiency. Registering a  CAGR  of  10.50%,  the global  Alpha-1 Antitrypsin Deficiency Treatment Market  is expected to grow from  USD 1,464.1 million  in 2018 to  USD 2,914.7 million  by  2025 . Alpha-1 Antitrypsin Deficiency Treatment   Market-Key Players: Kamada Pharmaceuticals CSL Behring LLC Grifols Takeda Pharmaceutical Company Limited GlaxoSmithKline plc Boehringer Ingelheim GmbH AstraZe...
Read more

Metastases Spinal Tumor Market Size Global Industry Share, Estimation, Demand, Trend, Challenges, Comprehensive Insights 2023

-
  The research study presented here is an intelligent take on Metastases Spinal Tumor Market Size research statistics by MRFR that explains important aspects such as competition, segmentation, and regional growth in great detaiL Metastases Spinal Tumor Market information: by type (extradural, and others), diagnosis (laboratory tests, imaging tests, biopsy, and others), by treatment (non- operative treatment, surgical treatment, and others), by end user- global forecast till 2023 The “Metastases Spinal Tumor Market” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Metastases Spinal Tumor Market Size Globally Register a CAGR of XX% To reach the Value of xx million USD during the forecast period. Emerging Global Opportunities in Metastases Spinal Tumor Market Growth By Major Companies, Future Trends, Technology, Indu...
Read more